Profil
Laurent Fraisse is currently the Director at genOway SA. He is also the EVP-Infectious Diseases Research & Development at Evotec (France) SAS. Additionally, he serves as a Member-Supervisory Board at Nosopharm SAS. Dr. Fraisse previously worked at Sanofi as a Member-Global Discovery Research Board.
He holds a doctorate degree from Institut National Polytechnique de Toulouse.
Postes actifs de Laurent Fraisse
| Sociétés | Poste | Début |
|---|---|---|
| GENOWAY | Directeur/Membre du Conseil | - |
Evotec (France) SAS
Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development of physical and natural sciences | Directeur Technique/Scientifique/R&D | 01/07/2018 |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Operates as anti-infective drug discovery platform | Directeur/Membre du Conseil | - |
Anciens postes connus de Laurent Fraisse
| Sociétés | Poste | Fin |
|---|---|---|
| SANOFI | Directeur Technique/Scientifique/R&D | - |
Formation de Laurent Fraisse
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Sanofi
Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
genOway SA
genOway SA BiotechnologyHealth Technology Develops gene technology | Health Technology |
Institut National Polytechnique de Toulouse
Institut National Polytechnique de Toulouse Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evotec (France) SAS
Evotec (France) SAS Miscellaneous Commercial ServicesCommercial Services Engages in research and development of physical and natural sciences | Commercial Services |
Nosopharm SAS
Nosopharm SAS Pharmaceuticals: MajorHealth Technology Operates as anti-infective drug discovery platform | Health Technology |
















